Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families

Journal of Investigative Dermatology

Volumn 134, Issue 2, 2014, Pages 481-487

  Liang, Xueying ^a,b   Pfeiffer, Ruth M ^a   Li, Wen Qing ^a   Brossard, Myriam ^c,d,e   Burke, Laura S ^a   Wheeler, William ^f   Calista, Donato ^g   Fargnoli, Maria Concetta ^h   Ghiorzo, Paola ^i,j   Peris, Ketty ^h   Bianchi Scarra, Giovanna ^i,j   Chaudru, Valerie ^c,d,k   Zelenika, Diana ^l   Maeder, Dennis ^a   Burdette, Laurie ^a   Yeager, Meredith ^a   Chanock, Stephen ^a   Landi, Maria Teresa ^a   Demenais, Florence ^c,d   Tucker, Margaret A ^a   Goldstein, Alisa M ^a   Yang, Xiaohong R ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INFORMATION MANAGEMENT SERVICES INC   (United States)

^g BUFALINI HOSPITAL   (Italy)

^h UNIVERSITY OF L'AQUILA   (Italy)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j UNIVERSITY OF GENOA   (Italy)

^k UNIVERSITÉ D EVRY VAL D ESSONNE   (France)

^l DIF   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER FAMILY; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; CUTANEOUS MELANOMA; DNA REPAIR; DYSPLASTIC NEVUS; FEMALE; GENE MUTATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MIDDLE AGED; PHENOTYPE; PIGMENTATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CYCLIN-DEPENDENT KINASE 6; DNA-BINDING PROTEINS; DYSPLASTIC NEVUS SYNDROME; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MELANOMA; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS;

EID: 84892821254     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.316     Document Type: Article

References (25)

1. Bishop JA, Wachsmuth RC, Harland M et al. (2000) Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol 114:28-33
2. Cannon-Albright LA, Meyer LJ, Goldgar DE et al. (1994) Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res 54:6041-4
3. De Snoo FA, Hottenga JJ, Gillanders EM et al. (2008) Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families. Eur J Hum Genet 16:1135-41
4. Dudbridge F, Koeleman BP (2003) Rank truncated product of P-values, with application to genomewide association scans. Genet Epidemiol 25:360-6
5. Duell EJ, Wiencke JK, Cheng TJ et al. (2000) Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21:965-71
6. Fargnoli MC, Spica T, Sera F et al. (2006) Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 98:144-5
7. Figl A, Scherer D, Nagore E et al. (2009) Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients. Mutat Res 661:78-84
8. Ghiorzo P, Bonelli L, Pastorino L et al. (2012) MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. Exp Dermatol 21:718-20
9. Goldstein AM, Landi MT, Tsang S et al. (2005) Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 14:2208-12
10. Goldstein AM, Struewing JP, Chidambaram A et al. (2000) Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 92:1006-10
11. Hussussian CJ, Struewing JP, Goldstein AM et al. (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15-21
12. Karahalil B, Bohr VA, Wilson DM III (2012) Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk. Hum Exp Toxicol 31:981-1005
13. Landi MT, Baccarelli A, Calista D et al. (2001) Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 85:1304-10
14. Landi MT, Kanetsky PA, Tsang S et al. (2005) MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 97:998-1007
15. Li Y, Willer CJ, Ding J et al. (2010) MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816-34
16. Liang XS, Pfeiffer RM, Wheeler W et al. (2011) Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanomaprone families with/without CDKN2A mutations. Int J Cancer 130: 2062-2066
17. Lunn RM, Langlois RG, Hsieh LL et al. (1999) XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59:2557-61
18. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer 9:153-66
19. Nelson HH, Kelsey KT, Mott LA et al. (2002) The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: Evidence of gene-environment interaction. Cancer Res 62:152-5
20. Pfeiffer RM, Gail M.H., Pee D (2001) Inference for covariates that accounts for ascertainment and random genetic effects in family studies. Biometrika 88:16
21. Russo AA, Tong L, Lee JO et al. (1998) Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395:237-43
22. Tucker MA, Fraser MC, Goldstein AM et al. (2002) A natural history of melanomas and dysplastic nevi: An atlas of lesions in melanoma-prone families. Cancer 94:3192-209
23. Tucker MA, Goldstein AM (2003) Melanoma etiology: Where are we? Oncogene 22:3042-52
24. Tucker MA, Halpern A, Holly EA et al. (1997) Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 277:1439-44
25. Williams RL (2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56:645-6